Summary of the second international sentinel node conferenceNIEWEG, Omgo E; TANIS, Pieter J; RUTGERS, Emiel J. T et al.European journal of nuclear medicine. 2001, Vol 28, Num 5, pp 646-649, issn 0340-6997Article

Sentinel Node Biopsy : Interpretation and Management of Patients With Immunohistochemistry-Positive Sentinel Nodes and Those With MicrometastasesRUTGERS, Emiel J. T.Journal of clinical oncology. 2008, Vol 26, Num 5, pp 698-702, issn 0732-183X, 5 p.Article

Breast-conserving therapy for Paget disease of the nipple:A prospective European Organization for Research and Treatment of Cancer Study of 61 patientsBIJKER, Nina; RUTGERS, Emiel J. T; DUCHATEAU, Luc et al.Cancer. 2001, Vol 91, Num 3, pp 472-477, issn 0008-543XArticle

Comparison of the sentinel node procedure between patients with multifocal and unifocal breast cancer in the EORTC 10981-22023 AMAROS Trial: Identification rate and nodal outcomeDONKER, Mila; STRAVER, Marieke E; DER MIJLE, Huub Van et al.European journal of cancer (1990). 2013, Vol 49, Num 9, pp 2093-2100, issn 0959-8049, 8 p.Article

The predictive value of the 70-gene signature for adjuvant chemotherapy in early breast cancerKNAUER, Michael; MOOK, Stella; RUTGERS, Emiel J. T et al.Breast cancer research and treatment. 2010, Vol 120, Num 3, pp 655-661, issn 0167-6806, 7 p.Article

Effects of Lycopene on the Insulin-Like Growth Factor (IGF) System in Premenopausal Breast Cancer Survivors and Women at High Familial Breast Cancer RiskVOSKUIL, Dorien W; VRIELING, Alina; VERHOEF, Senno et al.Nutrition and cancer. 2008, Vol 60, Num 3, pp 342-353, issn 0163-5581, 12 p.Article

Adjuvant Therapy in Stage I Carcinoma of the Breast: The Influence of Multigene Analyses and Molecular PhenotypingSCHWARTZ, Gordon F; REIS-FIHLO, Jorge; PUSZTAI, Lajos et al.Cancer. 2012, Vol 118, Num 8, pp 2031-2038, issn 0008-543X, 8 p.Article

Impact of mammographic screening on the detection of good and poor prognosis breast cancersESSERMAN, Laura J; SHIEH, Yiwey; VAN 'T VEER, Laura J et al.Breast cancer research and treatment. 2011, Vol 130, Num 3, pp 725-734, issn 0167-6806, 10 p.Article

Detection of extra-axillary lymph node involvement with FDG PET/CT in patients with stage II-III breast cancerAUKEMA, Tjeerd S; STRAVER, Marieke E; VRANCKEN PEETERS, Marie-Jeanne T. F. D et al.European journal of cancer (1990). 2010, Vol 46, Num 18, pp 3205-3210, issn 0959-8049, 6 p.Article

Micrometastases or Isolated Tumor Cells and the Outcome of Breast CancerDE BOER, Maaike; VAN DEURZEN, Carolien H. M; BULT, Peter et al.The New England journal of medicine. 2009, Vol 361, Num 7, pp 653-663, issn 0028-4793, 11 p.Article

Cost-Effectiveness of Screening Women With Familial Risk for Breast Cancer With Magnetic Resonance ImagingSAADATMAND, Sepideh; TILANUS-LINTHORST, Madeleine M. A; DE KONING, Harry J et al.Journal of the National Cancer Institute. 2013, Vol 105, Num 17, pp 1314-1321, issn 0027-8874, 8 p.Article

Factors affecting sensitivity and specificity of screening mammography and MRI in women with an inherited risk for breast cancerKRIEGE, Mieke; BREKELMANS, Cecile T. M; TILANUS-LINTHORST, Madeleine M. A et al.Breast cancer research and treatment. 2006, Vol 100, Num 1, pp 109-119, issn 0167-6806, 11 p.Article

Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predispositionKRIEGE, Mieke; BREKELMANS, Cecile T. M; MULLER, Sara H et al.The New England journal of medicine. 2004, Vol 351, Num 5, pp 427-437, issn 0028-4793, 11 p.Article

Breast-Conserving Treatment With or Without Radiotherapy in Ductal Carcinoma In Situ: 15-Year Recurrence Rates and Outcome After a Recurrence, From the EORTC 10853 Randomized Phase III TrialDONKER, Mila; LITIERE, Saskia; RUTGERS, Emiel J. T et al.Journal of clinical oncology. 2013, Vol 31, Num 32, pp 4054-4059, issn 0732-183X, 6 p.Article

Prophylactic Mastectomy in BRCA1 and BRCA2 Mutation Carriers: Very Low Risk for Subsequent Breast CancerKAAS, Reinoutje; VERHOEF, Senno; WESSELING, Jelle et al.Annals of surgery. 2010, Vol 251, Num 3, pp 488-492, issn 0003-4932, 5 p.Article

BRCA1- Associated Breast Cancers Present Differently From BRCA2-Associated and Familial Cases: Long-Term Follow-Up of the Dutch MRISC Screening StudyRIJNSBURGER, Adriana J; OBDEIJN, Inge-Marie; PETERSE, Hans et al.Journal of clinical oncology. 2010, Vol 28, Num 36, pp 5265-5273, issn 0732-183X, 9 p.Article

Differences between first and subsequent rounds of the MRISC breast cancer screening program for women with a familial or genetic predispositionKRIEGE, Mieke; BREKELMANS, Cecile T. M; KLIJN, Jan G. M et al.Cancer. 2006, Vol 106, Num 11, pp 2318-2326, issn 0008-543X, 9 p.Article

Is lymphatic mapping in breast cancer adequate and safe? : Can axillary dissection in breast cancer be avoided ?NIEWEG, Omgo E; RUTGERS, Emiel J. T; JANSEN, Liesbeth et al.World journal of surgery. 2001, Vol 25, Num 6, pp 780-788, issn 0364-2313Article

Differences in Natural History between Breast Cancers in BRCA1 and BRCA2 Mutation Carriers and Effects of MRI Screening-MRISC, MARIBS, and Canadian Studies CombinedHEIJNSDIJK, Eveline A. M; WARNER, Ellen; WARREN, Ruth M. L et al.Cancer epidemiology, biomarkers & prevention. 2012, Vol 21, Num 9, pp 1458-1468, issn 1055-9965, 11 p.Article

MRI-Model to Guide the Surgical Treatment in Breast Cancer Patients After Neoadjuvant ChemotherapySTRAVER, Marieke E; LOO, Claudette E; RUTGERS, Emiel J. T et al.Annals of surgery. 2010, Vol 251, Num 4, pp 701-707, issn 0003-4932, 7 p.Conference Paper

Role of Axillary Clearance After a Tumor-Positive Sentinel Node in the Administration of Adjuvant Therapy in Early Breast CancerSTRAVER, Marieke E; MEIJNEN, Philip; WESTENBERG, Helen A et al.Journal of clinical oncology. 2010, Vol 28, Num 5, pp 731-737, issn 0732-183X, 7 p.Conference Paper

Accurate axillary lymph node dissection is feasible after neoadjuvant chemotherapySTRAVER, Marieke E; RUTGERS, Emiel J. T; OLDENBURG, Hester S. A et al.The American journal of surgery. 2009, Vol 198, Num 1, pp 46-50, issn 0002-9610, 5 p.Article